Dr. Michael Schultz

Viewpoint Molecular receives $2M in SBIR funding
Dr. Michael Schultz, chief science officer with Viewpoint Molecular Targeting LLC in Coralville. CREDIT VMT By Katharine Carlon [email protected] An innovative new method of pinpointing the location of advanced skin cancer that has spread to other parts of the…